Author: Sree Roy

Home Testing Does Not Impact Clinical Outcomes

Home testing of obstructive sleep apnea (OSA) followed by initiation of home treatment with an auto-titrating continuous positive airway pressure (AutoCPAP or APAP) device reduced costs compared with in-laboratory testing and...

Read More

FDA Lowers Lunesta Starting Dose

The US Food and Drug Administration (FDA) announced it required the manufacturer of the sleep drug Lunesta (eszopiclone) to change the drug label and lower the current recommended starting dose. Data show that eszopiclone levels...

Read More